NEW MEDICAL PRODUCTS NEW PNEUMOCOCCAL VACCINE FOR CHILDREN
May 7, 2010
FDA has approved a new pneumococcal vaccine that provides broader protection for infants and young children ages six weeks through five years. The new vaccine, called Prevnar 13, is effective against 13 serotypes of the bacterium Streptococcus pneum...
Full Story Below
Rapid Response
Free Case Evaluation
The Help You Need,
When You Need it Most
More from FDA News Directory
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
lawyercen
